Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Medicus Pharma Ltd. before investing.

In this article, we go over a few key elements for understanding Medicus Pharma Ltd.’s stock price such as:

• Medicus Pharma Ltd.’s current stock price and volume
• Why Medicus Pharma Ltd.’s stock price changed recently
• Upgrades and downgrades for MDCX from analysts
• MDCX’s stock price momentum as measured by its relative strength

About Medicus Pharma Ltd. (MDCX)

Before we jump into Medicus Pharma Ltd.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Want to learn more about Medicus Pharma Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medicus Pharma Ltd..

Medicus Pharma Ltd.’s Stock Price as of Market Close

As of September 03, 2026, 12:46 PM, CST, Medicus Pharma Ltd.’s stock price was $0.169.

Medicus Pharma Ltd. is down 35.13% from its previous closing price of $0.260.

During the last market session, Medicus Pharma Ltd.’s stock traded between $0.151 and $0.210. Currently, there are approximately 55.06 million shares outstanding for Medicus Pharma Ltd..

Medicus Pharma Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Medicus Pharma Ltd. Stock Price History

Medicus Pharma Ltd.’s (MDCX) price is currently down 35.6% so far this month.

During the month of September, Medicus Pharma Ltd.’s stock price has reached a high of $0.260 and a low of $0.151.

Over the last year, Medicus Pharma Ltd. has hit prices as high as $3.050 and as low as $0.243. Year to date, Medicus Pharma Ltd.’s stock is down 88.98%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Medicus Pharma Ltd. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there were analysts who downgraded Medicus Pharma Ltd.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Medicus Pharma Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Medicus Pharma Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medicus Pharma Ltd. (MDCX) by visiting AAII Stock Evaluator.

Relative Price Strength of Medicus Pharma Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, Medicus Pharma Ltd. has a weighted four-quarter relative price strength of -37.30%, which translates to a Momentum Score of 4 and is considered to be Very Weak.

Want to learn more about how Medicus Pharma Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Medicus Pharma Ltd. Stock Price: Bottom Line

As of September 3, 2026, Medicus Pharma Ltd.’s stock price is $0.169, which is down 35.13% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Medicus Pharma Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.